Biotech Values

[rstor1]

Has anyone ever purchased a "round-table" forum transcript from The Wall Street Transcript? Was it useful? Was it worth the $175?

http://www.twst.com/info/info1113.htm

#

Roundtable Forum: Ronald J. Ellis Jr., Leerink Swan & Company; Edward H. Nash, Legg Mason Wood Walker; Thomas Shrader, Harris Nesbitt Corporation
#

Roundtable Forum – Investing in Small Cap Biotechnology: Reni J. Benjamin, Rodman & Renshaw, Inc.; Adam D. Cutler, JMP Securities LLC; Alexander A. Hittle, A.G. Edwards & Sons
#

Small Cap Biotechnology Stocks: Mark Karvosky, Piper Jaffray & Co.
#

CEO Interviews (average 2,500 words): Top management from 24 sector firms examine the outlook for their firm and the sector. Firms interviewed include: Aeolus Pharmaceuticals, Alfacell Corp., Amarillo Biosciences, Amylin Pharmaceuticals, Arena Pharmaceuticals, Astralis Ltd., avVaa World Health Care Products, Cambrex Corp., Celsion Corp., CytoGenix, Inc., Favrille, Genta Incorporated, Geron Corp., GTC Biotherapeutics, Human Genome Sciences, ID Biomedical Corp., Immune Response Corp., ReGen Therapeutics Plc, Tapestry Pharmaceuticals, Telik, Tercica, Zonagen and Zynex Medical.

Topics covered: Emerging therapies - Rise of competition - M&A Activity - FDA approvals - Congressional oversight - IPO environment - Venture capital interest - Clinical trials - American Jobs Creation Act

Companies covered: Biogen Idec’s (BIIB), Elan’s (ELN), Chiron (CHIR), MedImmune (MEDI), Genentech (DNA), Eyetech (EYET), Pfizer (PFE), Merck (MRK), Johnson & Johnson (JNJ), Novartis (NVS), GlaxoSmithKline (GSK), Genzyme (GENZ), Bone Care (BCII), Gilead (GILD), Telik (TELK), Progenics (PGNX), Anadys (ANDS), Nabi (NABI), Alexion (ALXN), AVI BioPharma (AVII), Human Genome Sciences (HGSI), Vertex (VRTX), Amarin (AMRN), MGI PHARMA (MOGN), SuperGen (SUPG), Incyte (INCY), Pfizer’s (PFE), Cubist Pharmaceuticals (CBST), Hybridon (HBY), Oscient Pharmaceuticals (OSCI), Vasogen (VSGN), Atherogenics (AGIX), Atherogenics (AGIX).

ORDER THIS REPORT NOW! ONLY $175